The Implications of the Inflation Reduction Act on Medicare Drug Strategies

Wednesday, December 7, 2022, | 2:00 p.m. – 3:00 p.m. Eastern Time


Following the recent passage of the Inflation Reduction Act (IRA), counties now have an opportunity to rethink how they provide prescription drug benefits for Medicare-eligible retirees.  

  • The practical and strategic implications of the IRA’s changes to Medicare Part D
  • The impact of the financing changes on plan design and funding, including:
  • Steps you should take now to address the IRA and questions for your actuary

*Hint: DO NOT use your own email if you are registering someone else. You must use the email of the person who will attend. It will also help to use the email that receives NACo correspondence (i.e. your county or organization email).​


If you have any registration questions, please email